WorldPingA breast cancer drug from AstraZeneca will now be available in England after a pricing deal was reached, in part a result of the U.S.-U.K. pharma pact.
Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.
When each newsroom published on this story, oldest first — all times UTC.
New hope for breast cancer patients as life-extending drug now on NHS in England
STAT+: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal
The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.
Read the full report at STATLiving hubs that keep updating as this story develops.
WorldPingEnhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.
Brief by WorldPing · Original reporting by BBC Health
WorldPingRolling coverage of the latest economic and financial news Bank of England urged to slow or halt bond-selling to slash UK borrowing costs The Guardian view on the Bank of England’s £120bn bill: power without accountability Newsflash: Britain’s econom…
Brief by WorldPing · Original reporting by The Guardian
Abu Bilal built a secret wall in his home to protect his books from Syria’s former Assad regime.
Brief by WorldPing · Original reporting by Al Jazeera
WorldPingScientists have discovered a crater on the moon that's bigger than the Roman Colosseum and is the result of a powerful impact two years ago that initially went undetected.
Brief by WorldPing · Original reporting by Phys.org
WorldPingForecasts of further rises in the inflation rate mean some analysts expect the Bank to act by the end of the year.
Brief by WorldPing · Original reporting by BBC Business
WorldPingThe Bank of England is expected to keep interest rates unchanged, despite rising inflation in the UK…
Brief by WorldPing · Original reporting by ABC News
WorldPing